Qingya Luo

1.2k total citations · 1 hit paper
15 papers, 779 citations indexed

About

Qingya Luo is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Qingya Luo has authored 15 papers receiving a total of 779 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 8 papers in Cancer Research and 2 papers in Surgery. Recurrent topics in Qingya Luo's work include RNA modifications and cancer (10 papers), RNA Research and Splicing (8 papers) and Cancer-related molecular mechanisms research (7 papers). Qingya Luo is often cited by papers focused on RNA modifications and cancer (10 papers), RNA Research and Splicing (8 papers) and Cancer-related molecular mechanisms research (7 papers). Qingya Luo collaborates with scholars based in China and United States. Qingya Luo's co-authors include Qinglv Wei, Ping Yi, Yang Yu, Jianhua Yu, Lanfang Li, Hualiang Xiao, Li Li, Jia Yu, Chunming Cheng and Dongling Zou and has published in prestigious journals such as Nucleic Acids Research, Nature Communications and PLoS ONE.

In The Last Decade

Qingya Luo

13 papers receiving 772 citations

Hit Papers

The m6A reader YTHDF1 promotes ovarian cancer progression... 2020 2026 2022 2024 2020 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The m6A reader YTHDF1 promotes ovarian cancer progression via augmenting EIF3C translation
    2020 530 citations Tao Liu, Qinglv Wei et al. Nucleic Acids Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qingya Luo China 9 725 427 90 65 48 15 779
Linxi Yang China 5 469 0.6× 292 0.7× 61 0.7× 65 1.0× 30 0.6× 15 529
Xichun Cui China 11 456 0.6× 322 0.8× 33 0.4× 58 0.9× 22 0.5× 14 520
Chunlong Yang China 11 616 0.8× 313 0.7× 36 0.4× 80 1.2× 45 0.9× 16 672
Tommy Fuchs Germany 7 642 0.9× 397 0.9× 48 0.5× 56 0.9× 11 0.2× 8 683
Hiroaki Hase Japan 12 573 0.8× 318 0.7× 33 0.4× 52 0.8× 26 0.5× 23 634
Jinzhuo Dou China 8 481 0.7× 235 0.6× 56 0.6× 90 1.4× 10 0.2× 10 517
Nils Degrauwe Switzerland 5 342 0.5× 198 0.5× 15 0.2× 59 0.9× 19 0.4× 7 431
Senxu Lu China 9 401 0.6× 316 0.7× 19 0.2× 48 0.7× 19 0.4× 9 460

Countries citing papers authored by Qingya Luo

Since Specialization
Citations

This map shows the geographic impact of Qingya Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qingya Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qingya Luo more than expected).

Fields of papers citing papers by Qingya Luo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qingya Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qingya Luo. The network helps show where Qingya Luo may publish in the future.

Co-authorship network of co-authors of Qingya Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Qingya Luo. A scholar is included among the top collaborators of Qingya Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qingya Luo. Qingya Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
2.
Wang, Yuya, Yifei Ren, Qinglv Wei, et al.. (2025). hnRNPL phase separation activates PIK3CB transcription and promotes glycolysis in ovarian cancer. Nature Communications. 16(1). 4828–4828.
3.
4.
Liu, Xiaoyi, Qinglv Wei, Hongyan Zhao, et al.. (2024). RNA m5C modification upregulates E2F1 expression in a manner dependent on YBX1 phase separation and promotes tumor progression in ovarian cancer. Experimental & Molecular Medicine. 56(3). 600–615. 27 indexed citations
5.
Chen, Yanjie, Qinglv Wei, Jie Xu, et al.. (2023). Upregulation of LRRC8A by m5C modification-mediated mRNA stability suppresses apoptosis and facilitates tumorigenesis in cervical cancer. International Journal of Biological Sciences. 19(2). 691–704. 41 indexed citations
6.
Wang, Haocheng, Qingya Luo, Qinglv Wei, et al.. (2021). YTHDF1 Aggravates the Progression of Cervical Cancer Through m6A-Mediated Up-Regulation of RANBP2. Frontiers in Oncology. 11. 650383–650383. 51 indexed citations
7.
Xu, Jing, Qingya Luo, Yi Liu, et al.. (2021). PHLDA1 Modulates the Endoplasmic Reticulum Stress Response and is required for Resistance to Oxidative Stress-induced Cell Death in Human Ovarian Cancer Cells. Journal of Cancer. 12(18). 5486–5493. 16 indexed citations
8.
Liu, Tao, Yang Yu, Qingya Luo, et al.. (2021). The RNA binding protein QKI5 suppresses ovarian cancer via downregulating transcriptional coactivator TAZ. Molecular Therapy — Nucleic Acids. 26. 388–400. 3 indexed citations
9.
Liu, Tao, Qinglv Wei, Jing Jin, et al.. (2020). The m6A reader YTHDF1 promotes ovarian cancer progression via augmenting EIF3C translation. Nucleic Acids Research. 48(7). 3816–3831. 530 indexed citations breakdown →
10.
Yu, Yang, Qinglv Wei, Yuling Tang, et al.. (2020). Loss of hnRNPA2B1 inhibits malignant capability and promotes apoptosis via down-regulating Lin28B expression in ovarian cancer. Cancer Letters. 475. 43–52. 54 indexed citations
11.
Li, Ziwei, Qingya Luo, Haocheng Wang, et al.. (2020). [Knockdown of YTH N6-methyladenosine RNA binding protein 2 (YTHDF2) inhibits cell proliferation and promotes apoptosis in cervical cancer cells].. PubMed. 36(3). 255–263. 8 indexed citations
12.
Zhao, Lianhua, et al.. (2016). Primary diffuse large B cell lymphoma arising from a leiomyoma of the uterine corpus. Diagnostic Pathology. 11(1). 9–9. 3 indexed citations
13.
Fang, Jingqin, et al.. (2016). Advanced MRI manifestations of trigeminal ganglioneuroma: a case report and literature review. BMC Cancer. 16(1). 694–694. 11 indexed citations
14.
Li, Lanfang, Qingya Luo, Guiqin Li, et al.. (2016). Characterization of the Expression of the RNA Binding Protein eIF4G1 and Its Clinicopathological Correlation with Serous Ovarian Cancer. PLoS ONE. 11(9). e0163447–e0163447. 17 indexed citations
15.
Zeng, Ying, Qiang Ma, Li Lin, et al.. (2015). Giant Myelolipoma in the Spleen. International Journal of Surgical Pathology. 24(2). 177–180. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Linxi Yang Breakdown of academic impact, for papers by Xichun Cui Breakdown of academic impact, for papers by Chunlong Yang Breakdown of academic impact, for papers by Tommy Fuchs Breakdown of academic impact, for papers by Hiroaki Hase Breakdown of academic impact, for papers by Jinzhuo Dou Breakdown of academic impact, for papers by Nils Degrauwe Breakdown of academic impact, for papers by Senxu Lu
Rankless by CCL
2026